Clinical Trial Update: Vinorelbine and XR9576 to Treat Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of vinorelbine with XR9576, a P-glycoprotein inhibitor, in patients with breast, lung, and ovarian cancers; the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Ovarian Cancer

Drugs mentioned

• Vinorelbine (Vinorelbine)
• XR9576 (tariquidar)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Cancer | Phase 1 | Status: COMPLETED